| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 11/09/2000 | WO2000066095A2 Use of estrone derivatives as antitumour agents |
| 11/09/2000 | CA2372493A1 Steroid derivatives |
| 11/08/2000 | EP0738275B1 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 11/08/2000 | EP0650495B1 Improved antiandrogens |
| 11/08/2000 | CN1272788A Method for treating psychosis associated with glucocorticoid related dysfunction |
| 11/07/2000 | US6143275 Type S3 N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
| 11/02/2000 | WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL |
| 11/01/2000 | CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition |
| 10/31/2000 | US6140316 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions |
| 10/25/2000 | CN1057769C Process for preparing 14 alpha, 17 alpha-bridged ethano-16 alpha-hydroxy-estratrienes medicinal compositions |
| 10/25/2000 | CN1057767C Androstanes with inducing hypothalamic effects |
| 10/25/2000 | CN1057673C Tablet, capsule, or granule comprising desogestrel |
| 10/24/2000 | US6136992 As anticancer agent; anticancer activity against wide variety of tumor cells lines, including lung, colon, central nervous system, melenoma, ovarian, renal, prostate and breast |
| 10/18/2000 | CN1057531C Androstanes steroids and their medicinal compositions and uses thereof |
| 10/17/2000 | US6133251 First stage daily dosage portion is natural estrogen, second stage daily dosage portion is a combination of natural estrogen and natural or synthetic gestogen, third stage daily dosage portion is natural estrogen, fourth dosage is placebo |
| 10/12/2000 | WO2000059920A2 Orally active 7.alpha.-alkyl androgens |
| 10/12/2000 | WO2000059447A2 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 10/12/2000 | CA2361885A1 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 10/11/2000 | EP1042352A1 Androgenic steroid compounds and a method of making and using the same |
| 10/11/2000 | CN1057305C Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceuticals |
| 10/05/2000 | WO2000029088A3 Recovery of organic solutes from aqueous solutions |
| 10/04/2000 | EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 09/28/2000 | WO2000056758A1 METHOD FOR PRODUCING 4,4-DIMETHYL-3β-HYDROXYPREGNA-8,14-DIENE-21-CARBOXYLIC ACID ESTERS AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD |
| 09/28/2000 | WO2000056757A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 09/28/2000 | DE19914019C1 Verfahren zur Herstellung von 4,4-Dimethyl-3beta-hydroxypregna-8,14-dien-21-carbonsäureestern, deren Verwendung und Zwischenprodukte im Verfahren A process for the preparation of 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters, their use and intermediates in the process |
| 09/28/2000 | CA2365081A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 08/30/2000 | CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn. |
| 08/30/2000 | CN1055930C Steroalkenol polyfluohydrocarbyl sulfonate compound and its deriv., use and preparing process |
| 08/30/2000 | CN1055929C Trifluoromethyl steroids compounds and prepn. thereof |
| 08/29/2000 | US6111085 Carbamate-derivatized nucleosides and oligonucleosides |
| 08/29/2000 | US6110906 Androgen derivatives for use in the inhibition of sex steroid activity |
| 08/22/2000 | US6107036 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 08/17/2000 | WO2000047603A2 16-hydroxyestratrienes as selective estrogens |
| 08/17/2000 | CA2359660A1 16-hydroxyestratrienes as selective estrogens |
| 08/16/2000 | EP0876391B1 Novel steroid esters useful against skin disorders |
| 08/15/2000 | US6103884 Glycosylated analogs of fusidic acid |
| 08/10/2000 | DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective |
| 08/02/2000 | EP1023074A1 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 07/27/2000 | WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/26/2000 | CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical |
| 07/19/2000 | EP0641355B1 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/11/2000 | US6087351 Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone |
| 07/11/2000 | CA2016780C Dihydrospirorenone as an antiandrogen |
| 07/06/2000 | WO2000039148A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 07/05/2000 | CN1259137A Estra-5(10), 7-dienes with estrogenic activity |
| 07/04/2000 | US6083940 Method and composition for effecting contraception in a mammalian male |
| 06/29/2000 | DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases |
| 06/28/2000 | EP1011607A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 06/27/2000 | US6080735 Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds |
| 06/14/2000 | CN1053450C Complete synthesizing process for compound of 17-substituted 11 beta-substituted aromatic base 4,9-estradiene |
| 06/13/2000 | CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates |
| 06/08/2000 | WO2000032201A2 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 06/08/2000 | WO2000032177A2 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections |
| 06/08/2000 | WO2000032176A2 Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis |
| 06/08/2000 | CA2356539A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of african and american trypanosomiasis |
| 06/08/2000 | CA2352387A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in treatment of toxoplasmosis and in the treatment of cryptosporidiosis |
| 06/08/2000 | CA2352205A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis c virus and other togaviruses |
| 06/06/2000 | US6072068 Treating glucocorticoid-dependent diseases or symptoms |
| 06/06/2000 | US6071410 Dry, non-conditioned sorbent medium comprising a blend of a polymethacrylate resin and a polystyrene resin. |
| 06/02/2000 | WO2000031112A1 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 05/25/2000 | WO2000029088A2 Recovery of organic solutes from aqueous solutions |
| 05/25/2000 | DE19848305C1 Conversion of propargyl alcohol derivatives to alpha,beta-unsaturated ketone or alkyne derivatives comprises reaction with an acidic cation-exchange resin in an organic solvent |
| 05/24/2000 | EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition |
| 05/24/2000 | CN1254344A Estrogenic 10-Noradnrost-17-one derivatives with aromatic B-ring |
| 05/24/2000 | CN1254341A Pharmaceutically accpetable salts of 3-hydroxy-estr-5-(10)-en-17-one 3-sulphate active as estrogens |
| 05/17/2000 | EP0871437B1 Use of boswellic acid for treating brain tumours |
| 05/17/2000 | CN1253564A Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 05/10/2000 | CN1252723A Use of 7 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis |
| 05/10/2000 | CN1052237C Steroids with 17-spiromethylene lactone or ortho -hydroxyl inner ether base |
| 05/09/2000 | US6060503 Antiestrogenic, anticarcinogenic stereospecific benzopyran derivative; breast cancer |
| 05/04/2000 | DE19850074A1 Stabilisierung von biologischen Flüssigkeiten durch Zusatz von Sterinestern Stabilization of biological fluids by the addition of sterol esters |
| 05/03/2000 | EP0997735A2 Stabilisation of biological fluids by addition of sterol esters |
| 04/27/2000 | WO2000023460A1 HIGH PURITY COMPOSITION COMPRISING (7α,17α)- 17-HYDROXY- 7-METHYL- 19-NOR-17-PREGN- 5(10)-EN-20-YN-3-ONE |
| 04/27/2000 | WO2000023080A1 IMPROVING MEMORY BY THE ADMINISTRATION OF Δ5-ANDROSTENE-3β-OL-7,17-DIONE AND 3β ESTERS THEREOF |
| 04/27/2000 | CA2344677A1 Improving memory by the administration of .delta.5-androstene-3.beta.-ol-7,17-dione and 3.beta. esters thereof |
| 04/26/2000 | EP0994713A1 USE OF A 7$g(a)-METHYL-17$g(a)-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 04/25/2000 | US6054598 Synthesis of 2-alkoxyestradiols |
| 04/25/2000 | US6054490 Use of sesquiterpenes for inhibiting oxidative enzymes |
| 04/20/2000 | WO2000021566A1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 04/18/2000 | US6051726 Benzylation and bromination |
| 04/12/2000 | EP0992512A2 Reduced cortisol conjugate |
| 04/05/2000 | EP0990662A1 Method of purifying tall oil sterol |
| 04/04/2000 | US6046185 6,7-oxygenated steroids and uses related thereto |
| 03/30/2000 | WO2000007576A3 INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE |
| 03/29/2000 | EP0988311A1 Betulinol derivatives |
| 03/22/2000 | EP0986573A1 Non-estrogenic estradiol derivatives with an antioxidant effect |
| 03/22/2000 | CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 03/15/2000 | EP0984979A1 Synthesis of 2-alkoxyestradiols |
| 03/14/2000 | US6037339 C-11 substituted steroids for treating menopausal complaints |
| 03/08/2000 | EP0983291A1 Carbamate-derivatized nucleosides and oligonucleosides |
| 03/08/2000 | EP0783513A4 Novel estrenes for inducing hypothalamic effects |
| 03/08/2000 | CN1246865A Antigestagenic steroids with fluorinated 17 'alpha'-alkyl chair |
| 03/01/2000 | EP0982592A2 Improved method of determining the amount of estradiol in a fluid sample and a respective kit therefor |
| 03/01/2000 | EP0982298A1 Novel functionalized hydrophilic acridinium esters |
| 03/01/2000 | EP0982032A2 Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production |
| 02/24/2000 | WO2000009101A2 Use of estrogenic compounds as anti-fungal agents |
| 02/23/2000 | EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 02/23/2000 | EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 02/17/2000 | WO2000007576A2 INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE |